The Stryker recall of the Rejuvenate and ABGII hip implants in July, 2012, left many implant recipients extremely concerned about their health and their future. After receiving FDA approval in 2008 and 2009, both models were marketed aggressively due to their new design which allowed surgeons the ability to fit the implants more precisely, according to the activity level and body size of the individual.

In April, 2012, Stryker Orthopedics issued an Urgent Field Safety Notice to hospitals and surgeons, warning them of the potential risks of the Rejuvenate and ABGII hip implants, including symptoms of Stryker cobalt toxicity.

The Stryker hip implant recall set off a flurry of lawsuits against the company as well as causing considerable amount of worry among the recipients of the recalled hip implants. Both the Rejuvenate and the ABGII were recalled in July, 2012 after a significant number of patients developed serious health symptoms following their Stryker implant surgery.

The Stryker hip recall of the company’s Rejuvenate and ABGII hip devices occurred in July, 2012. At the time of the Stryker hip recall Stryker noted that the combination of chromium, cobalt and titanium in the neck region of the recalled implants may fret and corrode, leading to serious medical conditions and chronic pain. The tiny metal shards released from the metal implants can inject themselves into the bloodstream of the implant recipient or can lodge within the tissue surrounding the hip. When the metal shards stop in the hip tissue, inflammation, infection and chronic pain can result. These symptoms are known as metallosis and are one reason for the Stryker hip recall.

Many Stryker corrosion lawyers have been working exhaustively since the recall of the Stryker Rejuvenate and ABGII hip implants in July of 2012. The Stryker Rejuvenate and ABGII were initially believed to be the “shining stars” of metal hip implants. This was due to an innovative design which allowed surgeons to more precisely fit the implant to body type and activity level. Despite the high hopes for the new hip implant design, Stryker corrosion attorneys note that adverse reports began coming in to the FDA not long after the approval of the devices in 2008 and 2009. Stryker corrosion lawyers have seen injuries to recipients of these recalled hip implants which range from minor to life-threatening.

Stryker metal poisoning symptoms can come without warning for those patients with a recalled Stryker Rejuvenate or ABGII metal hip implant. Patients who received a Rejuvenate or ABGII Stryker hip implant device following FDA approval for the devices in 2008 and 2009, believed these devices had been tested and were safe. In fact, literature for the devices assured patients that the innovative new design and the use of a ceramic ball made the Rejuvenate and ABGII much safer and long-lasting than the true all-metal hip devices. Unfortunately Stryker metal poisoning symptoms and metallosis symptoms were reported by patients soon after receiving their Stryker hip implant.

Across the nation, Stryker hip lawyers are working hard to assist those who were harmed by the recalled Stryker Rejuvenate or ABGII hip implant. Believing Stryker’s new design to be much safer than other metal-on-metal implants on the market, surgeons, patients and Stryker hip lawyers expected good results. Unfortunately, both models were recalled in July, 2012, with Stryker stating a higher-than-normal risk of fretting and corrosion. This corrosion could, in turn, lead to the release of metal ions and, eventually, total hip failure.

On July 6, 2012, Stryker Orthopedics announced it was recalling its Stryker Rejuvenate and ABGII hip implants and ceasing global production of the two models. Stryker hip attorneys note that at the time of the recall, the company stated there was a higher-than-normal risk of implant failure due to excessive fretting and corrosion. This excess corrosion was found to lead to a release of metal ions into the body. The tiny metal ions which settled around the hip joint resulted in excess inflammation in the area, pain for the patient, tissue and bone degradation, and even total hip failure. Some patients reported to their Stryker hip attorney that groin pain was also experienced.

Many recipients of the Stryker Rejuvenate may well wonder what events led up to the recall of the hip implant device in July, 2012. Was the company aware of the Stryker Rejuvenate design problems prior to releasing the device? Was the propensity for Stryker Rejuvenate fretting known? Was sufficient safety testing done prior to release of the Rejuvenate or was consumer safety sacrificed in favor of a larger profit margin? While the entire truth may never be known, many attorneys and consumers feel that, at the very least, Stryker downplayed the risks of the implant device, even at the time of the recall.

The Stryker Rejuvenate hip implant was recalled by Stryker in July, 2012 after numerous reports came in to the FDA regarding symptoms of metal toxicity and metallosis among recipients. Stryker cited a higher-than-normal rate of failure due to the likelihood of fretting and corrosion, leading to excess metal ion debris generation. The design of the Stryker Rejuvenate was considered extremely innovative at the time it was released. After many recipients of all-metal hip implant devices suffered significant health problems, the ceramic ball of the Rejuvenate was believed to be a safer alternative with fewer risks of metal ion shear